![David H. Katz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von David H. Katz
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David H. Katz
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
LifeCell Corp.
![]() LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Biotechnology | Director/Board Member | |
Orthovita, Inc.
![]() Orthovita, Inc. Medical SpecialtiesHealth Technology Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA. | Medical Specialties | Director/Board Member | |
Bioenvision, Inc.
![]() Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Adolor Corp.
![]() Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member | |
GIVEN IMAGING LTD. | Electronic Equipment/Instruments | Director/Board Member | |
Cobalis Corp.
![]() Cobalis Corp. Pharmaceuticals: OtherHealth Technology Cobalis Corp. is a pharmaceutical and nutraceutical company. Its flagship product, PreHistin designs to prevent the primary causes of airborne allergies. Cobalis specializes in the development of anti allergy medications. The company was founded in 1997 and is headquartered in Irvine, CA. | Pharmaceuticals: Other | Chairman | |
DFINE, Inc.
![]() DFINE, Inc. Medical SpecialtiesHealth Technology DFINE, Inc.engages in the development and commercialization of medical device system for treating vertebral compression fractures. The company was founded by John H. Shadduck and Csaba Truckai in 2004 and is headquartered in South Jordan, UT. | Medical Specialties | Director/Board Member | |
Cerexa, Inc.
![]() Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member | |
AVEDRO, INC. | Medical Specialties | Director/Board Member | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
GLAUKOS CORPORATION | Medical Specialties | Director/Board Member | |
GELESIS INC | Biotechnology | Chairman | |
Cerapedics, Inc.
![]() Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Auxillium Energy, Inc.
![]() Auxillium Energy, Inc. Oil & Gas ProductionEnergy Minerals Auxillium Energy, Inc. is an exploration stage company. It engages in the investigation, acquisition, exploration and development of oil and gas properties in Alaska. The company was founded on November 9, 2009 and is headquartered in White Plains, NY. | Oil & Gas Production | Director/Board Member | |
Arteaus Therapeutics LLC
![]() Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Denison University | College/University | Undergraduate Degree | |
Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
University of Florida | College/University | Doctorate Degree | |
University of San Diego | College/University | Graduate Degree | |
Emphasys Medical, Inc.
![]() Emphasys Medical, Inc. Medical SpecialtiesHealth Technology Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp. | Medical Specialties | Director/Board Member | |
INSULET CORPORATION | Medical Specialties | Director/Board Member | |
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
Tanabe Research Laboratories U.S.A., Inc.
![]() Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
OrbiMed Advisors Private Equity
![]() OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Hambro Resource Development, Inc. | Corporate Officer/Principal | ||
Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
OrbiMed Capital GP IV LLC | Corporate Officer/Principal | ||
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member | |
Immunetech Pharmaceuticals | Chief Tech/Sci/R&D Officer | ||
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Chairman | |
SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Societal CDMO San Diego LLC
![]() Societal CDMO San Diego LLC Pharmaceuticals: MajorHealth Technology Societal CDMO San Diego LLC engages in the development of pharmaceutical product. It specializes in formulation research and development, cGMP (current Good Manufacturing Practices) manufacturing of clinical trial materials and commercial pharmaceutical products, and consulting related to the drug development process. The company was founded by Gerald J. Yakatan in 1996 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
IriSys, Inc.
![]() IriSys, Inc. Pharmaceuticals: MajorHealth Technology IriSys, Inc. operates as an investment holding company with interests in pharmaceuticals. The company was founded was founded by Gerald J. Yakan on December 12, 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
GRI Operations, Inc.
![]() GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 46 |
Israel | 3 |
Kanada | 2 |
Dänemark | 2 |
China | 2 |
Sektoral
Health Technology | 35 |
Consumer Services | 5 |
Commercial Services | 4 |
Finance | 3 |
Health Services | 2 |
Operativ
Director/Board Member | 37 |
Independent Dir/Board Member | 12 |
Corporate Officer/Principal | 7 |
Chairman | 6 |
Chief Executive Officer | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jonathan Silverstein | 42 |
Gerald Yakatan | 12 |
Jagadish C. Sircar | 1 |
James E. Berg | 1 |
- Börse
- Insiders
- David H. Katz
- Unternehmensverbindungen